Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
The Journal of Infectious Diseases
|
November 1, 1982
Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child
C D Sibrack, L T Gutman, C M Wilfert, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1988
HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail
W P Parks, E S Parks, M A Fischl, et al.
The Journal of Infectious Diseases
|
December 1, 1977
Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines
F A Ennis, R E Mayner, D W Barry, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1987
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity
M N Ellis, P M Keller, J A Fyfe, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1985
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro
H Mitsuya, K J Weinhold, P A Furman, et al.
American Journal of Epidemiology
|
July 1, 1976
Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man
D W Barry, R E Mayner, E Staton, et al.
American Journal of Epidemiology
|
July 1, 1976
Comparative trial of influenza vaccines. II. Adverse reactions in children and adults
D W Barry, R E Mayner, H D Hochstein, et al.
Lancet (London, England)
|
March 15, 1986
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex
R Yarchoan, R W Klecker, K J Weinhold, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 1999
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1
G M Szczech, P Furman, G R Painter, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
The Journal of Infectious Diseases
|
November 1, 1982
Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child
C D Sibrack, L T Gutman, C M Wilfert, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1988
HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail
W P Parks, E S Parks, M A Fischl, et al.
The Journal of Infectious Diseases
|
December 1, 1977
Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines
F A Ennis, R E Mayner, D W Barry, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 1987
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity
M N Ellis, P M Keller, J A Fyfe, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1985
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro
H Mitsuya, K J Weinhold, P A Furman, et al.
American Journal of Epidemiology
|
July 1, 1976
Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man
D W Barry, R E Mayner, E Staton, et al.
American Journal of Epidemiology
|
July 1, 1976
Comparative trial of influenza vaccines. II. Adverse reactions in children and adults
D W Barry, R E Mayner, H D Hochstein, et al.
Lancet (London, England)
|
March 15, 1986
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex
R Yarchoan, R W Klecker, K J Weinhold, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 1999
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1
G M Szczech, P Furman, G R Painter, et al.
Page
of 4